NAYA NAYA Bio: Bozor kapitallashuvining balans qiymatiga nisbati

NAYA Bio (NAYA) - korporativ logo

GURU.Markets platformasidagi joriy bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati bahosi -0.11 ko'rsatkichini o'z ichiga oladi, u ushbu metrikaning miqdorini belgilaydi. NAYA Biosciences (NAYA) o'sishi INVO bilan integratsiya, antitanachlar terapiyasi sohasidagi muvaffaqiyatlar va IVF xizmatlariga asoslangan. FLEX-NK platformasi uchun olingan patentlar sotib olinishdan himoya vazifasini o'taydi, R&D laboratoriyalarining samaradorligi esa yuqori texnologik uskunalarning amortizatsiyasi ustidan qat'iy nazorat orqali ta'minlanadi.

NAYA Biosciences (NAYA) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 28.04.2025gacha

NAYA (NAYA Biosciences Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi NAYA Biosciences|NAYA - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi NAYA Bio|NAYA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati NAYA Biosciences|NAYA - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati nayabiosciences.com|NAYA - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati NAYA Biosciences|NAYA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati NAYA Bio|NAYA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati NAYA Bio
Fundamental baholash:NAYA (NAYA Biosciences)
NAYA Biosciences Inc tayyor mahsulotlari

Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlariga solishtirib, kapitaldan yuqori bo'lgan premiumni o'lchaydi. Investorlar ushbu metrikadan aktivlarning likvidatsiya qiymatiga nisbatan haddan tashqari qimmat baholanganligini baholash uchun foydalanadilar. Bozor qiymatining buxgalteriya qiymatiga nisbati dinamikasini tahlil qilish orqali kotirovkalarning qarz kapitali xarajatlariga sezgirligini aniqlash mumkin. NAYA Biosciences (NAYA) uchun bu daromadning yo'qligi va dori vositalarini ishlab chiqishning ilk bosqichlari tufayli juda muhimdir. Naqd pul tanqisligi xavfi spekulyativ kapitalga bog'liqlikni hal qiluvchi omilga aylantiradi.

Asosiy raqobatchilar

ONC: Bozor kapitallashuvining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBIT|Bozor qiymatining balans qiymatiga nisbati CEL-SCI Corporation CVM|Kapitallashuvning balans qiymatiga nisbati ostherapies.com (OSTX)|Bozor kapitallashuvining balans qiymatiga nisbati RADX (Radiopharm Theranostics)|ARTV - Bozor kapitallashuvining balans qiymatiga nisbati|ANL (Adlai Nortye Limited) - Kapitallashuvning sof aktivlarga nisbati|VERU - Bozor qiymatining balans qiymatiga koeffitsiyenti|TPST: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Xilio Therapeutics|RENB - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Mural Bio|Bozor kapitallashuvining balans qiymatiga nisbati Kairos Pharma Ltd (KAPA)|Bozor qiymatining balans qiymatiga nisbati onkuretherapeutics.com (OKUR)|Bozor kapitallashuvining balans qiymatiga nisbati GDTC|Curis Inc. - Balans qiymatiga nisbatan bozor kapitallashuvi|APLM (Apollomics Corp) - Bozor qiymatining balans qiymatiga nisbati|THAR: Bozor qiymatining balans qiymatiga koeffitsiyenti|advanbiomed.com - Bozor qiymatining balans qiymatiga nisbati|Genprex Inc (GNPX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati CLDI|Kapitallashuvning sof aktivlarga nisbati sunshinebiopharma.com|XBIO (Xenetic Biosciences) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Salarius Pharmaceuticals Inc (SLRX)|PPBT: Bozor kapitallashuvining balans qiymatiga nisbati|American Oncology Network Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|BeiGene, Ltd. (BGNE) - Bozor qiymatining balans qiymatiga nisbati|CKPT - Kapitallashuvning balans qiymatiga nisbati|ELEV (Elevation Oncology) - Bozor kapitallashuvining balans qiymatiga nisbati|iCAD (ICAD) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IKNA (Ikena Oncology Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti NTBL|VIRX (Viracta Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi MOR (morphosys.com)|AAPGV - Bozor qiymatining balans qiymatiga nisbati